© 2023 Replicate Bioscience | All rights reserved.
A segment of yellow, single-stranded RNA arcs across the right side of the page. Behind it is a blue-to-teal background overlaid with rows of simple human silhouettes. A bright white light trail animates following the arch of the RNA.
A segment of yellow, single-stranded RNA arcs across the right side of the page. Behind it is a blue-to-teal background overlaid with rows of simple human silhouettes. A bright white light trail animates following the arch of the RNA.

The Power of RNA Amplified

Impact measured in billions.

YOUR CELLs’ vERY OWN COPY MACHINERY

Our platform leverages next-generation self-replicating RNA (srRNA) vectors. Once inside cells, the genetic code of our srRNA drives repeated production of natural RNA, resulting in outsized protein expression and durable therapeutic effect.

OUR SCIENCe
A strand of srRNA floats upwards to the right. Behind it, copied mRNA segments are visible.
A strand of srRNA floats upwards to the right. Behind it, copied mRNA segments are visible.

ENABLING BROAd APPLICATIONs FOR RNA TREATMENTs

Replicate is advancing a robust pipeline of srRNA treatments spanning several therapeutic areas, including infectious disease, oncology, and autoimmune disorders. Improved performance over linear mRNA lets us help even more patients.

PIPELINe
A simple blue line-drawing pattern of human silhouettes arranged in three rows.
A simple blue line-drawing pattern of human silhouettes arranged in three rows.
A gradient blue background with a white, curved, light trail.
A gradient blue background with a white, curved, light trail.

News & Publications

11.04.23 Publications & Presentations
Self-replicating RNA therapeutics for the Off-the-Shelf Precision Immunotherapy targeting acquired resistance mutations in low TMB tumors
Read more
10.30.23 Press Releases
Replicate Bioscience to Present Progress on Two srRNA Oncology Programs at Society for Immunotherapy of Cancer 2023 Meeting
Read more
09.28.23 Perspectives
Dosing the first person with srRNA: Advancing a novel technology platform with a strategic development approach
Read more
VIEW ALL NEWs